Cargando…
Effective Utilization of Oral Hypoglycemic Agents to Achieve Individualized HbA1c Targets in Patients with Type 2 Diabetes Mellitus
Type 2 diabetes is a progressive condition that may require the combination of three oral treatments to achieve optimal glycemic management to prevent microvascular and macrovascular complications whilst minimizing the risk of acute complications and side effects or adverse reactions to treatments....
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5014794/ https://www.ncbi.nlm.nih.gov/pubmed/27502496 http://dx.doi.org/10.1007/s13300-016-0188-5 |
_version_ | 1782452328978186240 |
---|---|
author | Bannister, Margaret Berlanga, Jenny |
author_facet | Bannister, Margaret Berlanga, Jenny |
author_sort | Bannister, Margaret |
collection | PubMed |
description | Type 2 diabetes is a progressive condition that may require the combination of three oral treatments to achieve optimal glycemic management to prevent microvascular and macrovascular complications whilst minimizing the risk of acute complications and side effects or adverse reactions to treatments. With the widening availability of treatment options and increasing importance of individualized treatment pathways, including personalized HbA1c targets, this article will explore the mode of action of currently available oral treatments, factors to consider when individualizing HbA1c targets, the relevance of estimated glomerular filtration rate assessment, and the importance of reviewing the clinical impact of all treatment decisions. |
format | Online Article Text |
id | pubmed-5014794 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-50147942016-09-19 Effective Utilization of Oral Hypoglycemic Agents to Achieve Individualized HbA1c Targets in Patients with Type 2 Diabetes Mellitus Bannister, Margaret Berlanga, Jenny Diabetes Ther Commentary Type 2 diabetes is a progressive condition that may require the combination of three oral treatments to achieve optimal glycemic management to prevent microvascular and macrovascular complications whilst minimizing the risk of acute complications and side effects or adverse reactions to treatments. With the widening availability of treatment options and increasing importance of individualized treatment pathways, including personalized HbA1c targets, this article will explore the mode of action of currently available oral treatments, factors to consider when individualizing HbA1c targets, the relevance of estimated glomerular filtration rate assessment, and the importance of reviewing the clinical impact of all treatment decisions. Springer Healthcare 2016-08-08 2016-09 /pmc/articles/PMC5014794/ /pubmed/27502496 http://dx.doi.org/10.1007/s13300-016-0188-5 Text en © The Author(s) 2016 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Commentary Bannister, Margaret Berlanga, Jenny Effective Utilization of Oral Hypoglycemic Agents to Achieve Individualized HbA1c Targets in Patients with Type 2 Diabetes Mellitus |
title | Effective Utilization of Oral Hypoglycemic Agents to Achieve Individualized HbA1c Targets in Patients with Type 2 Diabetes Mellitus |
title_full | Effective Utilization of Oral Hypoglycemic Agents to Achieve Individualized HbA1c Targets in Patients with Type 2 Diabetes Mellitus |
title_fullStr | Effective Utilization of Oral Hypoglycemic Agents to Achieve Individualized HbA1c Targets in Patients with Type 2 Diabetes Mellitus |
title_full_unstemmed | Effective Utilization of Oral Hypoglycemic Agents to Achieve Individualized HbA1c Targets in Patients with Type 2 Diabetes Mellitus |
title_short | Effective Utilization of Oral Hypoglycemic Agents to Achieve Individualized HbA1c Targets in Patients with Type 2 Diabetes Mellitus |
title_sort | effective utilization of oral hypoglycemic agents to achieve individualized hba1c targets in patients with type 2 diabetes mellitus |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5014794/ https://www.ncbi.nlm.nih.gov/pubmed/27502496 http://dx.doi.org/10.1007/s13300-016-0188-5 |
work_keys_str_mv | AT bannistermargaret effectiveutilizationoforalhypoglycemicagentstoachieveindividualizedhba1ctargetsinpatientswithtype2diabetesmellitus AT berlangajenny effectiveutilizationoforalhypoglycemicagentstoachieveindividualizedhba1ctargetsinpatientswithtype2diabetesmellitus |